These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38411632)

  • 21. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
    Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
    J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of coronary artery disease severity on long-term outcomes in unprotected left main coronary artery revascularization.
    Kahraman S; Zencirkiran Agus H; Demirci G; Can C; Demir AR; Güner A; Kalkan AK; Uzun F; Ertürk M; Yıldız M
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):8-21. PubMed ID: 33390575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.
    Ndrepepa G; Neumann FJ; Cassese S; Fusaro M; Ott I; Schulz S; Hoppmann P; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
    Clin Res Cardiol; 2014 Jan; 103(1):49-56. PubMed ID: 24092474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of Renal Dysfunction at 1-Year Follow-Up on Clinical Outcomes After Percutaneous Coronary Intervention.
    Takahashi T; Watanabe T; Aono T; Otaki Y; Wanezaki M; Nishiyama S; Kutsuzawa D; Kato S; Tamura H; Arimoto T; Takahashi H; Watanabe M
    J Atheroscler Thromb; 2023 Jul; 30(7):786-794. PubMed ID: 36123047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial.
    Lee J; Ahn JM; Kim JH; Jeong YJ; Hyun J; Yang Y; Lee JS; Park H; Kang DY; Lee PH; Park DW; Park SJ;
    J Am Heart Assoc; 2021 Jul; 10(14):e020359. PubMed ID: 34227392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
    Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Zhang HP; Zhao Y; Li H; Tang GD; Ai H; Zheng NX; Liu JH; Sun FC
    Medicine (Baltimore); 2016 Jan; 95(2):e2441. PubMed ID: 26765429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease.
    Chen X; Zhang X; Yan Y; Zhao X; Nie M; Feng T; Liang Z; Zhao Q
    J Interv Cardiol; 2020; 2020():6736704. PubMed ID: 32372888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, predictors, prognostic significance, and effect of techniques on outcomes of coronary lesion calcification following implantation of drug-eluting stents: a patient-level pooled analysis of stent-specific, multicenter, prospective IRIS-DES registries.
    Lee CH; Ahn JM; Lee KS; Kang DY; Lee PH; Lee SW; Lee CW; Park SW; Park DW; Park SJ;
    Coron Artery Dis; 2021 Jan; 32(1):42-50. PubMed ID: 32310851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population.
    Chandwani P; Verma P; Saxena S; Ramachandran PK; Abhyankar A; Sandhu MS; Parikh N; Bhupali A; Jain S; Prajapati J
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):39-48. PubMed ID: 26585397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction.
    Jiang L; Xu L; Song L; Gao Z; Tian J; Sun K; Yu H; Xu B; Song L; Yuan J
    J Interv Cardiol; 2018 Jun; 31(3):310-318. PubMed ID: 29468730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan.
    Inohara T; Kohsaka S; Yamaji K; Ishii H; Amano T; Uemura S; Kadota K; Kumamaru H; Miyata H; Nakamura M
    BMJ Open; 2019 May; 9(5):e026683. PubMed ID: 31122979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.